Experimental Drug DNL343 Fails to Slow ALS Progression in Randomized Trial
A randomized clinical trial in JAMA Network Open found that 200 mg per day of DNL343, an eIF2B activator, did ...
A randomized clinical trial in JAMA Network Open found that 200 mg per day of DNL343, an eIF2B activator, did ...
A new fNIRS study shows that older adults with dementia reorganize their prefrontal networks into more segregated local clusters, and ...
A new review details how the CD47 don't eat me signal regulates efferocytosis and shapes disease outcomes in cancer, atherosclerosis ...
A comprehensive review in 3 Biotech details how plant-derived compounds such as polyphenols, flavonoids, and alkaloids can inhibit the toxic ...
A new study shows that cholesterol-conjugated heteroduplex oligonucleotides can silence alpha-synuclein in the mouse brain, protecting dopaminergic neurons through the ...
Injecting tau filaments from Alzheimer's and corticobasal degeneration patients into wild-type mice induces endogenous tau pathologies with identical folded structures, ...
A naturally occurring short isoform of the androgen receptor, AR-A, dramatically reduces aggregation and toxicity of the mutant protein causing ...
A new review in Science reveals that X and Y chromosomes independently shape disease risk and aging, offering a new ...
Researchers report that the trafficking protein Snapin drives neuronal PANoptosis after mild traumatic brain injury by disrupting hydrogen sulfide signaling ...
A phase 2b European trial found that SOM3355, a repurposed beta-blocker with a novel triple mechanism, significantly reduced chorea in ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine